FDA's Expedited IND Comment Window Nears Close After Gene Therapy Holds
FDA's comment window on the Expedited IND pilot closes July 22, 2026, after clinical holds hit REGENXBIO and Intellia gene therapy programs.
Technology, AI & Digital Security
The latest technology, ai & digital security journalism from the publications of the VUGA Enterprises Network — refreshed around the clock. Every headline opens the full story at its source.
Page 7 of 7 · Updated 7 Oct 2026, 18:23 UTC
Epoch AI's New EBR-Bench Finds Models Still Struggle to Learn From Experience
Epoch AI's EBR-bench, announced July 8, 2026, uses the board game Earthborne Rangers to test whether AI models improve with practice. So far, they don't.
Celltrion and Teva's Truxima Becomes First Interchangeable Rituximab Biosimilar in the US
FDA granted interchangeability designation to Celltrion and Teva's Truxima on July 1, 2026, the first rituximab biosimilar to achieve the status.
EU Privacy Regulators Set New Rules for Web Scraping in Generative AI
The EDPB adopted guidelines on web scraping for generative AI and opened consultation until October 30, 2026 — what changes for AI companies.
Gilead and Lakefront Complete $1.675 Billion Ouro Medicines Acquisition
The completed deal adds gamgertamig, a BCMAxCD3 T-cell engager with FDA Fast Track and Orphan Drug designations, to Gilead's inflammation pipeline.
Fox Will Buy Roku for $22 Billion in Cash and Stock
Fox agreed on June 15, 2026 to acquire Roku at $160 per share, roughly $22 billion enterprise value, with closing expected in the first half of 2027.
Parabilis Medicines Raises Record $670 Million Biotech IPO
Parabilis Medicines priced a $670 million IPO on June 9, 2026, the largest ever for a venture-backed biotech, extending 2026's streak of large listings.
Apple's New Siri AI Arrives as Beta in English Later This Year
Siri AI, previewed June 8, 2026 at WWDC26, adds on-screen awareness and web answers, with a staged rollout and disclosed limits.
FDA Accepts Vertex's Povetacicept BLA in IgA Nephropathy With November Decision
FDA accepted Vertex's povetacicept BLA for accelerated approval in IgA nephropathy with a November 30, 2026 PDUFA date, on 52% UPCR reduction data.
Apple Unveils iOS 27 and an All-New Siri AI at WWDC26
Apple's June 8, 2026 WWDC announcement covers iOS 27, a rebuilt Siri AI, faster performance claims, and new parental controls.
The VUGA Enterprises Newsroom aggregates headlines and short excerpts from the newspapers and magazines of the VUGA Enterprises Network. Every headline links to the full story on the publishing site. Part of the VUGA Network.